Trial
NCT01687478
A Study of Olanzapine and Fluoxetine for Treatment-resistant Depression
Phase IIITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Eli Lilly and Company
Collaborators
—
Condition
Treatment Resistant Depression
Intervention
Olanzapine
Why stopped
Interim assessment: Lack of efficacy
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-10-09